About Elligo
Elligo is a company based in Austin (United States) founded in 2016. Elligo has raised $176.48 million across 6 funding rounds from investors including Morgan Stanley, Cerner and Syneos Health. The company has 280 employees as of December 31, 2021. Elligo has completed 4 acquisitions, including ClinEdge, Protenium Clinical Research and Root Health. Elligo offers products and services including IntElligo®, Study Marketplace®, and Patient Select. Elligo operates in a competitive market with competitors including Acurian, Velocity Clinical Research, CenExel, Wake Research and ePatientFinder, among others.
- Headquarter Austin, United States
- Employees 280 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$176.48 M (USD)
in 6 rounds
-
Latest Funding Round
$40 M (USD), Debt – Venture
Oct 03, 2023
-
Investors
Morgan Stanley
& 12 more
-
Employee Count
280
as on Dec 31, 2021
-
Investments & Acquisitions
ClinEdge
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elligo
Elligo offers a comprehensive portfolio of products and services, including IntElligo®, Study Marketplace®, and Patient Select.
Platform for managing and enabling clinical trials efficiently
Technology for simplifying clinical trial site selection and placement
System for engaging patients in clinical research opportunities
People of Elligo
Unlock access to complete
Unlock access to complete
Funding Insights of Elligo
Elligo has successfully raised a total of $176.48M across 6 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $40 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Elligo
Elligo has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Morgan Stanley, Cerner and Syneos Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Structured debt is provided to life sciences and technology firms.
|
Locked | Locked | Locked | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked | |
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Locked | Locked | Locked |
Investor details for Elligo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elligo
Elligo has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include ClinEdge, Protenium Clinical Research and Root Health.
Investment portfolio details for Elligo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-based software for clinical trial patient communication is provided.
|
Locked | Locked | 2019 | Locked | |
|
Clinical trial recruitment service company
|
Locked | Locked | 2013 | Locked | |
|
Patient recruitment and business development services are provided by ClinEdge.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for Elligo
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Elligo
Detailed financials for Elligo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elligo Comparisons
Peer comparison for Elligo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elligo
Elligo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Acurian, Velocity Clinical Research, CenExel, Wake Research and ePatientFinder, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Patient enrollment and retention solutions for clinical trials are offered.
|
|
| Locked | Locked | Locked |
Provider of site management and patient recruitment services
|
|
| Locked | Locked | Locked |
Research site management and patient recruitment services are provided.
|
|
| Locked | Locked | Locked |
Clinical site management, patient recruitment, and retention services are provided.
|
|
| Locked | Locked | Locked |
Clinical trial recruitment service company
|
Detailed competitors of Elligo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elligo
Complete news archive for Elligo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elligo
Elligo was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Elligo is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Elligo is a funded company, having raised a total of $176.48M across 6 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Elligo is 280.
Elligo was founded in 2016 in Austin, United States, and operates as a contract research organization in the health research sector. Core services encompass patient recruitment, site activation, study initiation, and closeout processes. These activities support clinical trials by streamlining site operations and participant enrollment across various studies. The company maintains a focus on efficient research execution within the U.S. geography.
Elligo's top competitors include Velocity Clinical Research, Acurian and CenExel.
Elligo offers IntElligo®, Study Marketplace®, and Patient Select.
Elligo has made 4 acquisitions, including ClinEdge, Protenium Clinical Research, and Root Health.
Elligo has 13 investors. Key investors include Morgan Stanley, Cerner, Syneos Health, Piper Sandler, and Norwest Venture Partners.